Pular para o conteúdo
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • Effect of alemtuzumab or basil...
  • Citar
  • Enviar por SMS
  • Enviar por e-mail
  • Imprimir
  • Exportar registro
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
  • Link permanente
Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.

Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.

Detalhes bibliográficos
Principais autores: Plata-Munoz, J, Vaidya, A, Fuggle, S, Friend, P
Formato: Journal article
Idioma:English
Publicado em: 2009
  • Itens
  • Descrição
  • Registros relacionados
  • Registro fonte

Registros relacionados

  • Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
    por: Haynes, R, et al.
    Publicado em: (2014)
  • Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
    por: Haynes, R, et al.
    Publicado em: (2014)
  • Impact of monoclonal antibody based-induction therapy on postoperative graft function and survival of kidneys from non-heart-beating donors.
    por: Plata-Munoz, J, et al.
    Publicado em: (2007)
  • The deceased donor score system in kidney transplants from deceased donors after cardiac death.
    por: Plata-Munoz, J, et al.
    Publicado em: (2010)
  • Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
    por: Haynes, R, et al.
    Publicado em: (2014)

Opções de Busca

  • Histórico de buscas
  • Busca Avançada

Encontrar Mais

  • Navegar o acervo
  • Navegar por ordem alfabética
  • Explorar canais
  • Bibliografia Recomendada
  • Novos itens

Precisa de ajuda?

  • Dicas de Busca
  • Serviço de Referência
  • Perguntas Frequentes